Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Cut by Beacon Investment Advisory Services Inc.

Beacon Investment Advisory Services Inc. lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 69,953 shares of the medical equipment provider’s stock after selling 1,290 shares during the period. Intuitive Surgical accounts for 1.6% of Beacon Investment Advisory Services Inc.’s portfolio, making the stock its 16th biggest holding. Beacon Investment Advisory Services Inc.’s holdings in Intuitive Surgical were worth $36,513,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Massachusetts Financial Services Co. MA bought a new position in Intuitive Surgical in the 3rd quarter worth approximately $558,807,000. International Assets Investment Management LLC boosted its position in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares during the period. FMR LLC grew its stake in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB increased its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, State Street Corp raised its stake in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,487 shares of company stock valued at $22,590,975 in the last three months. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

ISRG stock opened at $610.45 on Thursday. The firm has a market capitalization of $217.43 billion, a P/E ratio of 98.14, a P/E/G ratio of 5.13 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $614.72. The company’s 50 day simple moving average is $544.61 and its 200-day simple moving average is $502.64.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. Robert W. Baird increased their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James raised their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Royal Bank of Canada upped their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.